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Introduction {#sec1}
============

The learning of new motor skills leads to the genesis of postsynaptic dendritic spines in the motor cortex, and the retention of motor memory is associated with the maintenance of these learning-related new spines ([@bib8], [@bib33], [@bib32], [@bib35], [@bib34]). Under pathological conditions such as those in Parkinson disease (PD), dendritic spines in the motor cortex present instability and high levels of turnover ([@bib11]). Agreeing with these findings, functional magnetic resonance imaging studies reveal pathological hyperactivity in the motor cortex of patients with PD ([@bib24], [@bib25], [@bib37]). Such evidence suggests dysfunctions of the motor cortex in motor learning impairments ([@bib11], [@bib25]). Therefore, further studies for the relationship among synaptic activity, spine activity, and motor function may provide implications for the intervention of motor disorders.

Many lines of evidence indicate that the generation and propagation of Ca^2+^ spikes in pyramidal neuron dendrites coordinate synaptic activity and facilitate synaptic potentiation and/or depotentiation ([@bib8], [@bib31]). Dendritic Ca^2+^ spikes participate in the strengthening and/or remodeling of dendritic spines during both development and motor learning ([@bib17]), whereas aberrant dendritic activity is associated with synaptic depotentiation in the diseased brain ([@bib3]). The generation of Ca^2+^ spikes is heavily regulated by local inhibitory interneurons, which also play an important role in modulating structural synaptic changes in pyramidal cells ([@bib13]). In Alzheimer disease (AD), dysfunction of somatostatin-expressing inhibitory interneurons (SST-INs) results in progressive hippocampal synapse loss ([@bib26]). Following repeated stress in mice, decreased activity of parvalbumin-expressing inhibitory interneurons causes a high rate of dendritic spine elimination in the somatosensory cortex ([@bib6]). In the motor cortex, a recent study showed that SST-INs are tightly correlated with learning-induced activities of pyramidal neurons ([@bib1]). However, no study has investigated the involvement of SST-INs under pathological conditions.

In this study, we generated an acute motor deficit model by introducing a single dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which led to impaired motor memory retention. *In vivo* imaging of the motor cortex revealed enhanced elimination of learning-related dendritic spines, increased pyramidal neuron dendritic activity, as well as decreased activities of SST-INs. Activation of SST-INs in the motor cortex restored dendritic Ca^2+^ activity and synaptic stability and improved motor skill retention. Our results suggest that targeting SST-INs may help to relieve MPTP-induced cortical dysfunction and motor deficits.

Results {#sec2}
=======

Dendritic Spine Instability and Motor Memory Deficits Induced by Single MPTP Infusion {#sec2.1}
-------------------------------------------------------------------------------------

We repeatedly imaged fluorescently labeled dendritic spines of layer 5 pyramidal neurons (L5PRNs) in the primary motor cortex using transcranial two-photon microscopy ([Figure 1](#fig1){ref-type="fig"}A). Results showed that a single intraperitoneal (i.p.) injection of MPTP (30 mg/kg) caused a 2-fold increase in dendritic spine turnover within 4--24 h in 1-month-old mice (MPTP versus vehicle, all in %, 4 h, 9.0 ± 0.54 versus 4.4 ± 0.58; 24 h, 18.2 ± 0.95 versus 10.4 ± 0.74; p \< 0.05 by t test in both cases; [Figures 1](#fig1){ref-type="fig"}B and 1C). The rates of spine formation and elimination were both higher in MPTP-treated mice than those in vehicle-treated control mice (MPTP versus vehicle, all in %, elimination: 4 h, 4.2 ± 0.36 versus 2.5 ± 0.40; 24 h, 8.0 ± 0.63 versus 4.2 ± 0.36; formation: 4 h, 5.3 ± 0.40 versus 1.9 ± 0.27; 24 h, 10.2 ± 0.57 versus 4.8 ± 0.39; p \< 0.05 by t test in all comparison pairs). These results indicate that MPTP has potent effects on dendritic spine dynamics in the cortex.Figure 1Systemic Administration of MPTP Destabilizes Dendritic Spines and Impairs Motor Memory(A) Upper, schematic diagram of *in vivo* two-photon imaging in apical dendrites of layer 5 pyramidal neurons (L5PRNs) in the motor cortex of *Thy1*-YFP mice. Lower, timeline of imaging and drug administration.(B) Representative two-photon images of the same dendritic segment in time series from vehicle or MPTP-treated groups. Filled arrowheads, newly formed spines; open arrowheads, eliminated spines.(C) From left to right, overall spine turnover, elimination, and formation rates during 0--4 h and 0--24 h. MPTP group showed significantly higher spine plasticity (two-sample student t test; 0--4 h and 0--24 h; turnover, *t*~8~ = 5.82, *t*~8~ = 6.51; elimination, *t*~8~ = 6.02, *t*~8~ = 6.99; formation, *t*~8~ = 3.15, *t*~8~ = 4.07; p \< 0.05 in all cases. *n* = 5 per group).(D) Experimental timeline of motor learning and two-photon microscopy.(E) Representative images of dendritic segments before (0) and after motor learning (8 h).(F) Spine formation rates over 0--8 h was significantly higher under learning paradigms (non-learning, *n* = 4; beam learning, *n* = 9; rotarod learning, *n* = 9; *F* ~(2, 19)~ = 7.231, p = 0.0046).(G--I) (G) Representative dendritic segments in time series before and after motor learning under various conditions. Filled arrowheads, newly formed spine at 8 h; asterisks, filopodia. (H and I) The survival rates of newly formed spines 12 and 24 h after (H) rotarod learning (8--12 h, *t*~7~ = 5.496, p = 0.0009; 8--24 h, *t*~7~ =5.941, p = 0.0006; *n* = 4 in rotarod + vehicle and *n* = 5 in rotarod + MPTP group) or (I) or beam walking learning (8--12 h, *t*~7~ = 5.130, p = 0.0014; 8--24 h, *t*~7~ = 4.050, p = 0.0049; *n* = 4 in beam + vehicle and *n* = 5 in beam + MPTP group).(J and K) Motor performance improvement 24 h and 4 days after (J) rotarod (24 h, *t*~7~ = 4.867, p = 0.0018; 4 days, *t*~7~ = 2.916, p = 0.0225) or (K) beam walking learning (24 h, *t*~7~ = 4.463, p = 0.0024; 4 days, *t*~6~ = 2.699, p = 0.0356).(L and M) Pearson correlation analysis showed that new spine survival rates (0--8--24 h) were positively correlated with performance improvement at 24 h in rotarod (*r* = 0.78, p = 0.0016; L) and beam walking (*r* = 0.69, p = 0.0058; M) assays. \*p \< 0.05. Data were presented as mean ± SEM. Scale bar, 5 μm.

Previous studies have shown that motor learning induces the rapid formation of new spines in the motor cortex, and the persistence of these new spines associated with motor learning is critical for motor memory retention ([@bib35]). We next investigated whether MPTP similarly altered the dynamics of motor learning-induced new spines ([Figure 1](#fig1){ref-type="fig"}D). We trained 1-month-old mice to run on an accelerating rotarod or perform a beam walking task, and immediately after motor skill learning, mice were treated with MPTP. Consistent with previous studies ([@bib17], [@bib33], [@bib35], [@bib34]), new spine formation increased significantly within 8 h after motor training when compared with untrained controls (all in %, non-learning, 4.4 ± 0.5; beam learning, 6.2 ± 0.3; rotarod learning, 6.8 ± 0.4; p \< 0.01 by t test for both comparison pairs; [Figures 1](#fig1){ref-type="fig"}E and 1F). We found that among new spines formed within 8 h after motor training, fewer spines persisted over next 4 h (8--12) or 16 h (8--24) in the MPTP-treated mice when compared with vehicle-treated controls (p \< 0.01 by t test for both rotarod and beam walking, [Figures 1](#fig1){ref-type="fig"}G--1I). Furthermore, motor performance improvement was lower in MPTP-treated mice 1 day or 4 days after motor training (p \< 0.05 by t test for both 1 day and 4 days, [Figures 1](#fig1){ref-type="fig"}J and 1K). There was a significant correlation between the percentages of motor training-related persistent new spines and motor skill performance improvement (Pearson correlation, rotarod learning, *r* = 0.78; p = 0.0016; beam learning, *r* = 0.69; p = 0.0058; [Figures 1](#fig1){ref-type="fig"}L and 1M). Together, these results demonstrate dendritic spine instability and impaired motor memory retention by single MPTP administration.

Increased Ca^2+^ Spike Generation in Apical Tuft Dendrites of Pyramidal Neurons {#sec2.2}
-------------------------------------------------------------------------------

Previous studies have correlated dendritic spine dynamics with the dendritic activity of pyramidal neurons ([@bib8], [@bib31]). To study cortical activity in MPTP-treated mice, we performed *in vivo* Ca^2+^ imaging in apical tuft branches of L5PRNs ([Figure 2](#fig2){ref-type="fig"}C). Wild-type (WT) mice were given intracranial injection of an adeno-associated virus (AAV) delivered vector encoding the Ca^2+^ indicator GCaMP6s to monitor pyramidal neuron activity ([Figure S1](#mmc1){ref-type="supplementary-material"}). First, the levels of Ca^2+^ activity in dendritic spines exhibited a 3-fold increase in MPTP-treated mice when compared with vehicle treatment (p \< 0.0001 by t test, [Figures 2](#fig2){ref-type="fig"}A and 2B). In addition to Ca^2+^ activity in spines, we also observed a substantial increase in dendritic Ca^2+^ spikes following systemic MPTP injection: the number of Ca^2+^ spikes in the field of view (FOV) rapidly increased within 1 h post-injection, reached the peak level at 2 h, and remained higher than the pre-injection baseline at 4 h (p \< 0.0001 by two-way ANOVA; [Figure 2](#fig2){ref-type="fig"}D). Vehicle treatment had no effects on the generation of dendritic Ca^2+^ spikes ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). Analyses of individual dendrites showed significantly higher Ca^2+^ frequency and integrated Ca^2+^ levels 2 h after MPTP injection relative to pre-injection (p \< 0.0001 by two-way ANOVA; [Figures 2](#fig2){ref-type="fig"}E--2H, [Video S1](#mmc2){ref-type="supplementary-material"}). The amplitudes of dendritic Ca^2+^ spikes were comparable before and after MPTP injection ([Figure S2](#mmc1){ref-type="supplementary-material"}C). These MPTP-induced dendritic Ca^2+^ spikes were largely reduced in the presence of locally delivered *N*-methyl-[d]{.smallcaps}-aspartate (NMDA) receptor antagonist MK801 (p \< 0.0001 by t test; [Figures 2](#fig2){ref-type="fig"}I and 2J). These results show that MPTP injection causes an increase of dendritic spine and branch activity in pyramidal neuron tufts.Figure 2Systemic Administration of MPTP Increases Ca^2+^ Activity in Apical Dendrites of L5PRNs(A) Representative fluorescence images of dendritic spines in apical tufts of L5PRN expressing GCaMP6s over 50-s time series. Dotted circles, region of interest (ROI) showing Ca^2+^ transients in spines.(B) MPTP injection significantly increased frequency (*t*~98~ = 9.30, p \< 0.0001) and total integrated levels (*t*~98~ = 7.32, p \< 0.0001) of Ca^2+^ transients in dendritic spines. Vehicle, *n* = 50 ROIs from four animals; MPTP, *n* = 50 ROIs from four animals.(C) Experimental design for apical dendritic imaging after MPTP.(D) The number of Ca^2+^ spikes in the same field of view (FOV) over hours after MPTP systemic administration (one-way ANOVA, *F*~(3,\ 44)~ = 10.18, p \< 0.0001; *n* = 12 FOVs from five mice). Gray, individual traces; blue, averaged levels.(E) Time-series and z-stacked images showing dendritic Ca^2+^ spikes within 50 s from the same FOV before (pre-MPTP) or 2 h after drug infusion (post-MPTP).(F) Representative fluorescence traces of L5PRN apical tufts expressing GCaMP6s.(G) Distribution of Ca^2+^ spike frequency from individual dendritic segments during 3-min sampling windows. MPTP injection significantly increased Ca^2+^ frequency (*t*~305~ = 3.15, p \< 0.0001; *n* = 61 ROIs before MPTP and *n* = 246 ROIs post-MPTP from five animals).(H) Total integrated dendritic Ca^2+^ levels were enhanced by MPTP application (*t*~305~ = 4.74, p \< 0.0001).(I) Schematic showing MK801 local injection and dendritic Ca^2+^ recording in MPTP-treated mice.(J) Local application of MK801 reduced dendritic Ca^2+^ spike frequency and averaged dendritic Ca^2+^ activity after MPTP systemic injection (*n* = 88, *t*~332~ = 5.54, p \< 0.0001).\*p \< 0.05. Data were presented as mean ± SEM. Scale bar, 10 μm. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Video S1. Example of Ca^2+^ Spikes before and after Systemic Administration of MPTP, Related to Figure 2

To further understand the effects of MPTP on the cortex, we topically applied MPTP (30 μM in artifical cerebrospinal fluid, aCSF) to the superficial layer of the motor cortex and performed *in vivo* Ca^2+^ imaging on apical dendrites of L5PRNs ([Figure 3](#fig3){ref-type="fig"}A). We found that the number of Ca^2+^ spikes in the FOV increased markedly over 30 min after MPTP local application and returned to the baseline 2 h post-washout (150 min post-MPTP) (p \< 0.05 by t test, [Figures 3](#fig3){ref-type="fig"}B--3D, [Video S2](#mmc3){ref-type="supplementary-material"}). Both frequency and integrated activity of dendritic Ca^2+^ spikes peaked at 30 min after MPTP application and recovered to pre-injection levels 2 h post-washout (p \< 0.0001 by two-way ANOVA, [Figures 3](#fig3){ref-type="fig"}E and 3F). The amplitudes of dendritic Ca^2+^ spikes induced by local MPTP are similar to those that occurred after systemic MPTP injection ([Figure 2](#fig2){ref-type="fig"}). These results suggest that MPTP-induced dendritic Ca^2+^ spikes are partly mediated by its local action on the cerebral cortex.Figure 3Local Application of MPTP Increases Dendritic Ca^2+^ Activity(A) Experimental diagram and timeline of MPTP local application and two-photon imaging in L5PRN apical dendrites.(B) The frequency of dendritic Ca^2+^ spikes rapidly increased after local application of MPTP and returned to baseline levels 150 min later (*F*~(2,\ 33)~ = 160.4, p \< 0.0001; *n* = 12 fields of view \[FOVs\] from four mice). Gray, individual traces; blue, averaged levels.(C) Time-series and z-stacked images showing dendritic Ca^2+^ spikes within 50 s from the same FOV before (pre-MPTP), 30 min after (post-MPTP), and 2 h after removal of drugs (MPTP-recovery). Scale bar, 10 μm.(D) Representative fluorescence traces of L5PRN apical dendrites expressing GCaMP6s.(E) Distribution of dendritic Ca^2+^ spike frequency in individual dendrites over 3-min recording showed significantly elevated Ca^2+^ activity after local MPTP infusion (*F*~(2,\ 247)~ = 23.51; p \< 0.0001; *n* = 35, 165, and 50 regions of interest from pre-MPTP, post-MPTP, and MPTP-recovery groups, respectively, from four animals).(F) MPTP application reversibly increased dendritic Ca^2+^ activity averaged over 3-min recording (*F*~(2,\ 247)~ = 47.38, p \< 0.0001) \*p \< 0.05. Data were presented as mean ± SEM.

Video S2. Example of Ca^2+^ Spikes before and after Local Application of MPTP, Related to Figure 3

Decreased Activity in Somatostatin-Expressing Inhibitory Interneurons {#sec2.3}
---------------------------------------------------------------------

To understand the mechanisms underlying MPTP-induced dendritic activity in pyramidal neurons, we examined the activity of local inhibitory interneurons, focusing on dendritic-targeting SST-INs. These cells project their axons to the superficial layers of the cortex, where they primarily target pyramidal neuron dendrites and form inhibitory synapses ([@bib29]). To determine the effects of MPTP on SST-IN activity, we used *in vivo* Ca^2+^ imaging to examine the activity of SST-INs expressing GCaMP6s. Here, SST-*IRES*-Cre mice were injected with a Cre-dependent AAV-dio-GCaMP6s into the motor cortex to induce the expression of GCaMP6s specifically in SST-INs ([Figures 4](#fig4){ref-type="fig"}A and 4B). In contrast to the increased activity of dendritic spines and branches in L5PRNs ([Figure 2](#fig2){ref-type="fig"}), we found that the activity of SST-IN somas was significantly reduced within 1 h after MPTP injection (p \< 0.01 by t test, [Figures 4](#fig4){ref-type="fig"}C--4E). This reduction in SST-IN activity was also observed in their axon fibers projecting to layer 1 (p \< 0.01 by t test, [Figures 4](#fig4){ref-type="fig"}F--4H), indicating that MPTP induces a marked reduction of SST-IN activities in the motor cortex.Figure 4MPTP Decreases SST-IN Activity in the Motor Cortex(A) Left, experimental timeline; middle, expression of GCaMP6s in the motor cortex; right, *in vivo* Ca^2+^ imaging of SST-INs expressing GCaMP6s. Yellow arrowhead indicates activated SST-IN soma. Scale bar, 200 μm in middle panel and 50 μm in right panel.(B) Schematic diagram showing two-photon imaging planes in the superficial layer of the motor cortex.(C--E) (C) Representative fluorescence traces of GCaMP6s-labeled SST-IN somas before and after MPTP injection. Recording duration: 150 s. (D and E) Distribution (D) and quantitative analysis (E) of total integrated Ca^2+^ in SST-IN somas (*t*~129~ = 3.15, p = 0.002; *n* = 65 somas from pre-MPTP and *n* = 66 somas from post-MPTP in four mice).(F) Representative Ca^2+^ traces of SST-IN axons before and after MPTP injection.(G and H) Distribution (G) and quantitative analysis (H) of total integrated Ca^2+^ in SST-IN axons (*t*~334~ = 6.011, p \< 0.0001; *n* = 182 axons from pre-MPTP and *n* = 154 axons from post-MPTP in four mice).\*p \< 0.05. Data were presented as mean ± SEM.

Activation of SST-INs Reduces Dendritic Ca^2+^ Spikes in MPTP-Treated Mice {#sec2.4}
--------------------------------------------------------------------------

Previous studies have shown that SST-INs regulate dendritic Ca^2+^ spike generation in apical tuft dendrites of pyramidal neurons ([@bib7]). To test whether the decreased SST-IN activity contributes to MPTP-induced dendritic Ca^2+^ spikes in L5PRNs, we activated SST-INs *in vivo* by using the designer receptors exclusively activated by designer drugs (DREADD). In this experiment, we infected SST-INs in the motor cortex with AAV encoding Cre-dependent hM3Dq DREADD receptors in SST-*IRES*-Cre mice ([Figure 5](#fig5){ref-type="fig"}A). An i.p. injection of DREADD receptor ligand, clozapine-N-oxide (CNO), selectively activated hM3Dq-expressing SST-INs as reported by cFos immunostaining ([Figure 5](#fig5){ref-type="fig"}B). To test the effect of SST-IN activation on MPTP-induced dendritic activity in L5PRNs, we imaged GCaMP6s-expressing apical dendrites in mice expressing hM3Dq in SST-INs ([Figures 5](#fig5){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}). Dendritic Ca^2+^ activities were measured before and after CNO injection in MPTP-treated mice. We found that activation of SST-INs substantially reduced the number of dendritic Ca^2+^ spikes within 1 h and such effects persisted for at least 4 h (p \< 0.0001 by two-way ANOVA, [Figures 5](#fig5){ref-type="fig"}C--5E, [Video S3](#mmc4){ref-type="supplementary-material"}). Analyses of individual dendrites revealed a reduction of both Ca^2+^ spikes\' frequency and total integrated Ca^2+^ levels after the activation of SST-INs (p \< 0.001 by t test, [Figures 5](#fig5){ref-type="fig"}F and 5G). Comparing among all the treatment groups, activation of SST-INs reduced the number of dendritic Ca^2+^ spikes in MPTP-treated mice to levels that are comparable with the pre-MPTP group ([Figure S4](#mmc1){ref-type="supplementary-material"}). Taken together, these findings indicate that activation of SST-INs in the motor cortex is sufficient to suppress pyramidal neuron dendritic hyperexcitability induced by MPTP.Figure 5Chemogenetic Activation of SST-INs Reduces MPTP-Induced Pyramidal Neuron Dendritic Activity(A) Experimental timeline. In brief, AAV-*hsyn*-GCaMP6s and AAV-*dio*-hM3Dq-mCherry viruses were injected into layer 5 and layer 2 or 3 of the motor cortex of SST-*IRE*S-Cre mice, respectively. MPTP and CNO were sequentially applied 18 days after viral infection, along with two-photon imaging.(B) Immunofluorescence images of the motor cortex (upper left and lower panels) showing cFos-positive neurons among mCherry-transfected cells. CNO injection remarkably increased the co-labeling ratio (*t*~8~ = 56.67, p \< 0.0001; *n* = 5 animals per group; upper right panel). Filled arrowheads, cFos-positive neurons. Scale bar, 500 μm in top panel and 50 μm in lower panels.(C) The frequency of L5PRN dendritic Ca^2+^ spikes in the same field of view (FOV) increased after MPTP administration and decreased after CNO injection (*F* ~(3, 48)~ = 17.98, p \< 0.0001; *n* = 13 FOVs from five mice).(D and E) (D) Time-series and z-stacked images showing dendritic Ca^2+^ spikes over 50 s in the same FOV before (MPTP + pre-CNO) and after CNO injection (MPTP + post-CNO). Scale bar, 10 μm. (E) Representative fluorescence traces of dendritic Ca^2+^ spikes in L5PRNs.(F) Distribution of Ca^2+^ spike frequencies in individual dendrites over 3 min before and after MPTP and CNO injection. CNO injection reduced the frequency of dendritic Ca^2+^ spikes (*t*~214~ = 3.77, p = 0.0002; *n* = 164 regions of interest from MPTP + pre-CNO and *n* = 52 from MPTP + post-CNO in four mice).(G) Ca^2+^ activity in apical dendrites averaged over 3-min recording before and after CNO injection (*t*~214~ = 5.84, p \< 0.0001).\*p \< 0.05. Data were presented as mean ± SEM. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

Video S3. Example of Ca^2+^ Spikes before and after CNO Injection, Related to Figure 5

Activation of SST-INs Alleviates Dendritic Spine Instability and Motor Memory Deficits {#sec2.5}
--------------------------------------------------------------------------------------

We next investigated whether activation of SST-INs could rescue dendritic spine loss and motor memory deficits induced by acute MPTP infection. We crossed SST-*IRES*-Cre mice with *Thy1*-YFP mice and bilaterally injected Cre-dependent AAV-dio-hM3Dq-mCherry into the primary motor cortex ([Figure 6](#fig6){ref-type="fig"}A). Mice were trained on the accelerating rotarod motor learning task and administered MPTP and CNO 8 h after training. The cFos immunofluorescent staining showed that a single injection of CNO activated more than 75% of hM3Dq-expressing cells ([Figure 6](#fig6){ref-type="fig"}B). When dendritic spine plasticity was examined, we found that CNO treatment significantly increased the survival rates of learning-induced new spines in the motor cortex (p \< 0.01 by t test for both 8--12 h and 8--24 h, [Figures 6](#fig6){ref-type="fig"}C and 6D). Furthermore, CNO-treated mice showed higher performance improvement in the rotarod task 24 h or 4 days after initial training (p \< 0.01 by t test, [Figure 6](#fig6){ref-type="fig"}E). Notably, the improvement of rotarod performance positively correlated with the survival rate of training-related persistent new spines (p = 0.0042; *r* = 0.77, [Figure 6](#fig6){ref-type="fig"}F), suggesting that activation of SST-INs can rescue spine instability and motor memory deficits induced by acute MPTP infusion.Figure 6Activation of SST-INs Alleviates MPTP-Induced Dendritic Spine Loss and Motor Memory Deficits(A) Experimental timeline.(B) Immunostaining of the motor cortex (upper left and lower panels) and quantification analysis showing prominent activation of mCherry-positive SST-INs after CNO injection (*t*~6~ = 55.98, p \< 0.0001; *n* = 4 per group). Filled arrowheads, cFos-positive neurons. Scale bar, 500 μm in top panel and 50 μm in lower panels.(C) Representative dendritic segments from L5PRN apical tufts before rotarod skill learning (0), after learning and MPTP and/or CNO injection (8 h), and afterward (12--24 h). Filled arrowheads, newly formed spines at 8 h; asterisks, filopodia. Scale bar, 5 μm.(D) CNO injection enhanced the survival rates of newly formed spines within 8- to 12-h and 8- to 24-h time windows (8--12 h, *t*~6~ = 6.35, p = 0.0007; 8--24 h, *t*~6~ = 4.378, p = 0.0047; *n* = 4 per group).(E) Performance improvement (fold increase normalized to that in the learning session at 0 h) was elevated at 24 h and 4 days after initial learnings (24 h: *t*~6~ = 4.099, p = 0.0064; 4 days: *t*~6~ = 5.493, p = 0.0015).(F) Pearson correlation analysis showed positive correlation between new spine survival rates (0--8--24 h) and rotarod performance improvements at 24 h (*r* = 0.77; p = 0.0042).\*p \< 0.05. Data were presented as mean ± SEM.

Discussion {#sec3}
==========

In this study, we investigated the effects of acute MPTP treatment on synaptic plasticity and motor memory functions. Using two-photon microscopy, we found that a single injection of MPTP in adolescent mice destabilized dendritic spines on apical dendrites of L5PRNs in the motor cortex, which is associated with an increase of pyramidal neuron dendritic activity and a decrease of SST-IN activity. Notably, activation of SST-INs in the motor cortex following MPTP administration rescued pyramidal cell dendritic and synaptic deficits and preserved motor skill learning memory. Together, our results show that SST-IN dysfunction in the motor cortex plays an important role in synaptic and learning deficits induced by acute MPTP administration. As one parkinsonism-inducing agent, chronic MPTP exposure causes dopamine neuron degeneration, leading to learning and behavioral abnormalities ([@bib11], [@bib12]). The current study reported that a single dose of MPTP (30 mg/kg) led to impaired retention of motor skills that were acquired before the MPTP exposure, in association with the loss of learning-related new synapse structure, hyperactivity of pyramidal neuron dendrites, and suppression of SST-IN activity. These results indicate that at early stage of PD, motor cortex dysfunction may form one pathological feature and that targeting SST-INs has the potency to retard the progression of motor syndromes.

Structural and functional synaptic plasticity in the primary motor cortex has been shown to be critical for motor skill learning and retention ([@bib8], [@bib33], [@bib35], [@bib34]). Previous studies reported that rotarod learning over 8 h in 1-month-old mice causes a 2%--4% increase in new spine formation in the motor cortex ([@bib17], [@bib34]). Learning-induced new spines persist over days to weeks, and the survival of these new spines strongly correlates with the animals\' performance on motor skill tasks. After acute MPTP administration, we observed a marked increase in dendritic spine dynamics and a substantial loss of learning-induced new spines. This rapid loss of dendritic spines after MPTP exposure may contribute to the impairments of motor skill retention in these mice. To capture the functional plasticity of cortical spines, we employed *in vivo* Ca^2+^ imaging and observed a 3-fold increase in Ca^2+^ activity in dendritic spines after MPTP injection. Previous studies in different neurological diseases, such as seizure ([@bib27]), AD ([@bib3]), and neuropathic pain ([@bib7]), have linked overload of Ca^2+^ to the shrinkage or elimination of dendritic spines. MPTP-induced loss of dendritic spines, therefore, could be attributed to the increased Ca^2+^ transients in pyramidal neuron dendrites and spines. Moreover, we found that MPTP-induced dendritic Ca^2+^ spikes are NMDA receptor dependent, as blockade of NMDA receptor with MK801 normalized dendritic activity in cortical pyramidal neurons. Together, these results suggest that cortical pyramidal neuron dendritic hyperactivity may contribute to MPTP-induced synapse loss and motor memory impairments.

The activities of pyramidal neurons in the cortex are regulated by a great variety of local inhibitory interneurons. Among them, SST-INs constitute ∼30% of all cortical interneurons ([@bib29]). Although SST-INs themselves are a heterogeneous population and target different cells in different layers, they mainly innervate the distal portion of apical dendrites ([@bib13], [@bib21], [@bib29]). It has been shown that SST-INs regulate dendritic spine activity and dendritic Ca^2+^ spike generation ([@bib7], [@bib8]). Consistent with the increase of dendritic activity in our acute MPTP administration model, we observed a rapid and substantial decrease of SST-IN activity within 60 min after MPTP infusion, which is in favor of dendritic hyperactivity. Interestingly, measures from postmortem brain of patients with PD-related dementia showed reduced SST immunoreactivity in the cortex ([@bib2], [@bib4], [@bib9]), and decreased expression of SST in pluripotent stem cells derived from patients with *Parkin* mutations ([@bib15]), supporting the involvement of SST-INs in PD pathogenesis.

Given the reduction of SST-IN activity after MPTP administration, we manipulated the activity of SST-INs using chemogenetic approach and showed that SST-IN activation in the motor cortex prevented MPTP-induced increase in dendritic Ca^2+^ spike generation ([Figure S4](#mmc1){ref-type="supplementary-material"}), dendritic spine loss, and motor memory impairments. Activation of GABAergic inhibitory interneurons in cortical circuits has been shown to be beneficial in treating multiple neurological disorders with the characteristic of cortical hyperexcitability, including major depressive disorder ([@bib10], [@bib18]), neuropathic pain ([@bib7]), AD ([@bib26], [@bib30]), and PD ([@bib19], [@bib28], [@bib38]). It is worth to note that besides SST-INs, there are other types of interneurons located in the superficial layer of the cerebral cortex ([@bib22]). These cells are known to target apical tuft dendrites, and their activation can suppress Ca^2+^ spike generation in L5PRNs.

To explore the molecular mechanisms underlying MPTP-induced memory deficits, we examined the amounts of various proteins in the cortex after MPTP treatment, focusing on those involved in synaptic plasticity and function ([@bib16], [@bib36]). Previous studies have shown that activation of Ca^2+^/calmodulin-dependent kinase II (CaMKII) (Adler et al.; [@bib16], [@bib20]) and small GTPase proteins ([@bib14]) facilitates the long-term potentiation of dendritic spines in hippocampal slices. Using western blot analysis, we found that MPTP injection had no significant effects on the total amounts of CaMKII in the brain but caused a marked reduction in the level of CaMKII phosphorylated at Thr-286 (p-CaMKII) when compared with vehicle-treated controls at 4--12 h ([Figure S5](#mmc1){ref-type="supplementary-material"}). These results indicate that MPTP treatment acutely impairs CaMKII autophosphorylation in the cortex. Importantly, CNO treatment of SST-*IRES*-Cre mice infected with hM3Dq exhibited normal levels of p-CaMKII 4 h after MPTP injection, whereas the levels of cofilin, Ras1, RhoA, cdc42, and Rac1 remained unaltered ([Figure S5](#mmc1){ref-type="supplementary-material"}). CaMKII autophosphorylation is an important regulator of synaptic plasticity ([@bib5], [@bib16], [@bib23]), and its impairments have been observed in mouse hippocampus after acute or chronic MPTP infusion ([@bib39]). More importantly, a recent study suggested that pharmacological inhibition of CaMKII phosphorylation can disrupt motor learning ([@bib1]). The fact that SST-IN activation also corrects CaMKII autophosphorylation further suggests that manipulating SST-IN activity could be an important approach for preventing cortical hyperexcitability and motor memory impairments.

In sum, our current work demonstrates rapidly hyperactivated dendritic spines in the motor cortex after acute MPTP infusion, in association with spine loss plus motor dysfunctions. The activation of SST-INs helps to relieve these pathological phenotypes to recover motor learning function. Future studies will be needed to examine whether other types of interneurons could also be targeted to protect synaptic loss and motor learning deficits in MPTP-treated mice.

Limitations of the Study {#sec3.1}
------------------------

Our results demonstrate that potentiation of cortical SST-INs could relieve dendritic hyperactivity, spine loss, and motor learning deficits after acute MPTP injection. The current study, however, does not address if similar strategy can be used under chronic MPTP administration, which is one typical model of PD. Moreover, the long-term ameliorating effect from chemogenetics activation approach has not been evaluated. Further studies are thus required to address those issues to get a more complete picture of inhibitory transmission in motor cortical dysfunction.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods and Figures S1--S5
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